Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2026 | 01-2025 | 01-2024 | 01-2023 | 01-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13 | 8 | 37 | 8 | 174 |
| Receivables | 3 | 12 | 40 | 17 | 325 |
| Other current assets | 204 | 205 | 248 | 49 | 644 |
| TOTAL | $220 | $225 | $325 | $75 | $1,143 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | N/A | 0 | 18 |
| TOTAL | $0 | $0 | $0 | $0 | $18 |
| Total Assets | $220 | $225 | $325 | $75 | $1,161 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 785 | 871 | N/A | 80 | 278 |
| Accounts payable and accrued liabilities | 3,951 | 4,495 | 4,977 | 5,436 | 3,341 |
| Other current liabilities | 115 | 313 | 4 | N/A | 0 |
| TOTAL | $6,679 | $7,538 | $6,827 | $7,147 | $4,143 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27 | 49 | 328 | N/A | 35 |
| Other Non-Current Liabilities | -3,298 | -3,315 | -2,838 | -3,174 | 0 |
| TOTAL | $27 | $49 | $1,194 | $461 | $899 |
| Total Liabilities | $6,706 | $7,587 | $8,021 | $7,608 | $5,042 |
| Shareholders' Equity | |||||
| Common Shares | 81,962 | 79,965 | 78,460 | 76,572 | 75,385 |
| Retained earnings | -120,091 | -118,596 | -115,076 | -112,187 | -103,170 |
| Other shareholders' equity | 28,345 | 27,953 | 25,808 | 24,887 | 23,905 |
| TOTAL | $-9,784 | $-10,678 | $-10,809 | $-10,728 | $-3,881 |
| Total Liabilities And Equity | $-3,078 | $-3,090 | $-2,788 | $-3,120 | $1,161 |